Efficacy and safety of voriconazole as an additive in Optisol GS: A preservation medium for corneal donor tissue

Cornea

Volumn 26, Issue 3, 2007, Pages 343-347

  Ritterband, David C ^a   Shah, Mahendra K ^a,b   Meskin, Seth W ^a   Seedor, John A ^a   Koplin, Richard S ^a   Perez, Wilma ^a,b   Yang, Renee ^a   Hu, Dan Ning ^a,b   Dahl, Patricia ^c  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c Eye Bank for Sight Restoration   (United States)

Author keywords

Cornea storage media; Endophthalmitis; Optisol GS; Voriconazole

Indexed keywords

ALIZARIN RED S; PRESERVATIVE; TRYPAN BLUE; VORICONAZOLE;

ARTICLE; CORNEA PRESERVATION; CYTOTOXICITY TEST; DONOR; DRUG EFFICACY; DRUG SAFETY; ELECTRON MICROSCOPY; FUNGUS GROWTH; HUMAN; HUMAN CELL; MICROBIOLOGICAL EXAMINATION; PRIORITY JOURNAL; STANDARD;

ANTIFUNGAL AGENTS; CELL COUNT; CELL SURVIVAL; CHONDROITIN SULFATES; COMPLEX MIXTURES; CORNEA; CULTURE MEDIA, SERUM-FREE; DEXTRANS; DRUG COMBINATIONS; ENDOTHELIUM, CORNEAL; FUNGI; GENTAMICINS; HUMANS; MIDDLE AGED; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PYRIMIDINES; TISSUE DONORS; TREATMENT OUTCOME; TRIAZOLES;

EID: 34147190732     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e31802d82e8     Document Type: Article

References (43)

1. Ehlers N. World eye banking. Acta Ophthalmol (Copenh). 1997;75:481.
2. Leveille AS, McMullin FD, Cavanaugh HD. Endophthalmitis following penetrating keratoplasty. Ophthalmology. 1983;90:38-39.
3. Antonios SR, Cameron JA, Badr IA, et al. Contamination of donor cornea; postpenetrating keratoplasty endophthalmitis. Cornea. 1991;10:217-220.
4. Aiello LP, Javit JC, Canner JK. National risks of endophthalmitis and retinal detachment following penetrating keratoplasty. Arch Ophthalmol. 1993;111:509-513.
5. Kloess P, Stulting RD, Waring GO. Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Ophthalmol. 1993;115:309-316.
6. Rehany U, Balut G, Lefler E, et al. The prevalence and risk factors for donor corneal button contamination and its association with ocular infection after transplantation. Cornea. 2004;23:649-654.
7. Wiffen SJ, Weton BC, Maguire LJ, et al. The value of routine corneal rim cultures in penetrating keratoplasty. Arch Ophthalmol. 1997;115:719-724.
8. Hassan SS, Wilhelmus KR, Medical Review Subcommittee for the Eye Bank Association of America: Eye-banking risk factors for fungal endophthalmitis compared with bacterial endophthalmitis after cornea transplantation. Am J Ophthalmol. 2005;139:685-690.
9. Taban M, Behrens A, Newcomb RL, et al. Incidence of acute endophthalmitis following penetrating keratoplasty: a systematic review. Arch Ophthalmol. 2005;123:605-609.
10. Chu YI, Penland RL, Wilhelmus KR. Chlorimetric indicators of microbial contamination in corneal preservation medium. Cornea. 2000;19:517-520.
11. Merchant A, Zacks CM, Wilhelmus K, et al. Candidal endophthalmitis after keratoplasty. Cornea. 2001;20:226-263.
12. Sutphin JE, Pfaller MA, Hollis RJ, et al. Candida albicans after corneal transplantation. Am J Ophthalmol. 2002;134:120-121.
13. Cameron JA, Badr IA, Risco JM, et al. Endophthalmitis cluster from contaminated donor corneas following penetrating keratoplasty. Can J Ophthalmol. 1998;33:8-13.
14. Garcia Serranno JL, Dominguez I, Serrano Laborda D. Endoftalmitis recurrente en queratoplastia penentrante, por flora mixta. Arch Soc Esp Oftalmol. 2004;79:89-92.
15. Mishler KE, Keates RH. Clinical safety of corneal storage media. Ophthalmic Surg. 1977;8:23-24.
16. Keyhani K, Seedor J, Shah M, et al. The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea. 2005;24:288-291.
17. Mathers WD, Lemp MA. Corneal rim cultures. Cornea. 1987;6:231-233.
18. Farrell PL, Fan JT, Smith RE, et al. Donor cornea bacterial contamination. Cornea. 1991;10:381-386.
19. Ainley R, Smith B. Fungal flora of the conjunctival sac in healthy and diseased eyes. Br J Ophthalmol. 1965;49:505-515.
20. Williamson J, Gordon AM, Wood R, et al. Fungal flora of the conjunctival sac in health and disease. Influence of topical and systemic steroids. Br J Ophthalmol. 1968;52:127-137.
21. Ando N, Takatori K. Fungal flora of the conjunctival sac. Am J Ophthalmol. 1982;94:3367-3374.
22. Mindrup EA, Dubbel PA, Doughman DJ. Betadine decontamination of donor globes. Cornea. 1993;12:234-239.
23. Dixon DM, Graham CR Jr, Shaffer RM, et al. Fungal flora from diabetic and non-diabetic human donor corneas. Cornea. 1984;3:281-284.
24. Maas-Reijs J, Pels E, Tullo AB. Eye banking in Europe 1991-1995. Acta Ophthalmol Scand. 1997;75:541-543.
25. Hagenah M, Bohnke M, Engelmann K, et al. Incidence of bacterial and fungal contamination of donor corneas preserved by organ culture. Cornea. 1995;14:423-426.
26. Pels L. Organ culture: the method of choice for preservation media. Br J Ophthalmol. 1997;81:523-525.
27. Thuret G, Carricajo A, Vautrin AC, et al. Efficiency of blood culture bottles for the fungal sterility testing of corneal organ culture media. Br J Ophthalmol. 2005;89:586-590.
28. Saggau DD, Bourne WM, Sinkeldam IR, et al. Replication of fungi in K-sol corneal preservation medium at 4°C. Arch Ophthalmol. 1986;104:1362-1363.
29. Pels E, Vrensen GFJM. Microbial decontamination of human donor eyes with povidone-iodine: penetration, toxicity, and effectiveness. Br J Ophthalmol. 1999;83:1019-1026.
30. Hoffman HL, Rathburn RC. Review of the safety and efficacy of voriconazole. Expert Opin Investig Drugs. 2002;11:852-856.
31. Jeu L, Piacenti FJ, Lyakhovetskiy AG, et al. Voriconazole. Clin Ther. 2003;25:1321-1381.
32. Espinel-Ingroff A. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic monilaceous and dematiaceous fungi. J Clin Microbiol. 2001;39:954-958.
33. Cuenca-Estrella M, Diaz-Guerra TM, Mellado E, et al. Comparative in vitro activity of voriconazole and itraconazole against fluconazole-susceptible and fluconazole-resistant clinical isolates of Candida species from Spain. Eur J Clin Microbiol Infect Dis. 1999;18:432-435.
34. Sanati H, Belanger P, Frati R, et al. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei. Antimicrob Agents Chemother. 1997;41:2492-2496.
35. Marangon FB, Miller D, Giaconi JA, et al. In vitro investigation of voriconazole susceptibility of keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004;137:820-825.
36. Scott IU, Cruz-Villegas V, Flynn HW Jr, et al. Delayed-onset Bleb-associated endophthalmitis caused by Lecythophora mutablis. Am J Ophthalmol. 2004;137:583-585.
37. Ozbek Z, Kang S, Sivalingam J, et al. Voriconazole in the management of alternaria keratitis. Cornea. 2006;25:242-244.
38. Howell A, Midturi J, Sierra-Hoffman P, et al. Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin. Med Mycol. 2005;43:651-655.
39. Kim JE, Perkins SL, Harris GJ. Voriconazole treatment of fungal scleritis and epibulbar abscess resulting from scleral buckle infection. Arch Ophthalmol. 2003;121:735-737.
40. Isla Tejera B, Garzas Martin de Almagro C, Cardenaas Aranzana M, et al. Stability and in vitro activity of voriconazole eyedrops at a concentration of 3 microg/mL. Farm Hosp. 2005;29:331-334.
41. Hoppe-Tichy T, Wenzel S, Gehrig AK, et al. Stability of voriconazole in infusion bags. Pharmazie. 2005;60:77-78.
42. Singh G, Bohnke M, von-Domarus D, et al. Vital staining of corneal endothelium. Cornea. 1985;86:80-91.
43. Taylor MJ, Hunt CJ. Dual staining of corneal endothelium with trypan blue and alizarin red S: importance of pH for the dye-lake reaction. Br J Ophthalmol. 1981;65:815-819.